Trial intelligence / Profile preview

Remimazolam Tosilate vs Midazolam in Elderly Patients Undergoing Gastrointestinal Endoscopy

NCT04656964Completed

Sponsor
Peking University People's Hospital
Start
Apr 2021
Primary completion
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of remimazolam in Procedural sedation (PS) (2 arms), sponsored by Peking University People's Hospital. Primary endpoint: Recovery time after operation at Day 0. Started Apr 2021; status: completed.

02

Drugs

remimazolam
03

Conditions

Procedural sedation (PS)

Beyond the preview

Go deeper on NCT04656964.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04656964.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call